Completed PHASE4 INTERVENTIONAL 1-arm NCT00440245

Bronchoprotection of Salbutamol in Asthma and Chronic Obstructive Pulmonary Disease

Bronchoprotection of Salbutamol in Asthma and COPD

Sponsor: University of Saskatchewan

Interventions salbutamol

Updated 7 times since 2017 Last updated: Mar 25, 2020 Started: Feb 28, 2007 Primary completion: Jul 31, 2010 Completion: Jul 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Asthma and COPD, this trial is completed. The trial is conducted by University of Saskatchewan and has accumulated 7 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Apr 2020 — Jan 2021 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Nov 2018 — Apr 2020 [monthly]

Recruiting PHASE4

▶ Show 2 earlier versions

Jun 2018 — Nov 2018 [monthly]

Recruiting PHASE4
Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE4

First recorded

Feb 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Saskatchewan

Data source: University of Saskatchewan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Saskatoon, Canada